Aliza Thompson

Company: FDA

Job title: Deputy Director of the Division of Cardiology & Nephrology

Seminars:

Panel Discussion: Navigating Earlier Endpoint Development to Predict Clinical Outcome in Shorter Clinical Trials 11:00 am

Can we move towards harmonizing global regulatory endpoints? Non-invasive imaging, patient-reported outcomes, albuminuria and UACR: driving progress in elevating alternative outcome measures Can we incorporate patient reported outcomes in symptomatic kidney diseases?Read more

day: Day One

Regulatory Perspective on Endpoint Development: How is the Regulatory Landscape Evolving with Advances in Research? 9:30 am

Establishing a clinical pathway to correlate promising biomarkers with clinical outcome Advancing understanding of efficacy with the endpoints we already have Evaluating the regulatory landscape for paediatric and ultra-rare clinical studies and driving diversity in clinical trialsRead more

day: Day One